Bile Acid Receptors and Liver Cancer

81Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

Abstract

Liver cancer, particularly hepatocellular carcinoma (HCC), is the third leading cause of cancer death in the world. Bile acids (BAs) are liver-produced amphipathic molecules that are required to facilitate the absorption of cholesterol, fat-soluble vitamins, and lipids in the intestine. However, BAs are also known to act as potential carcinogens and deregulation of BA homeostasis has been linked to HCC formation. Two key BA receptors, farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (TGR5), were recently identified, which provides great insights into BAs’ normal physiological functions as well as their carcinogenic effects. In this review, we focus on the potential links among BAs, two BA receptors, and HCC. FXR and TGR5 not only play key roles in regulating BA homeostasis but also are essential in suppressing BAs’ carcinogenic effects on liver cancer.

Cite

CITATION STYLE

APA

Wang, X., Fu, X., Van Ness, C., Meng, Z., Ma, X., & Huang, W. (2013, March 1). Bile Acid Receptors and Liver Cancer. Current Pathobiology Reports. Springer. https://doi.org/10.1007/s40139-012-0003-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free